TALMEDICA · MEDICAL AFFAIRS ADVISORY
Is your Medical Affairs model built for the market you're in?
Independent Medical Affairs advisory for biotech and pharma leaders making decisions about field strategy, organizational design, and capabilities as products, teams, and markets evolve.
Request an advisory discussionWHEN LEADERS CALL
When leaders need an independent perspective
Inherited a Field Medical team?
Understand what you inherited before deciding what to change.
Preparing for launch?
Build the field model around the clinical and market challenges the launch will actually face.
Reorganizing Medical Affairs?
Understand which capabilities, responsibilities, and institutional knowledge may be lost.
Reassessing Field Medical effectiveness?
Understand whether your field structure, capabilities, and resources still align with medical priorities and market needs.
HOW WE HELP
Medical Affairs strategy, organizational design, and capabilities
UNDERSTAND WHAT'S HAPPENING
Assessments & Organizational Readiness
Field Medical effectiveness, launch readiness, and organizational evaluations.
Featured: Field Medical Baseline
HELP LEAD THE WORK
Fractional Medical Affairs Leadership
Experienced leadership for pre-launch buildouts, organizational transitions, and specific strategic workstreams.
STRENGTHEN THE LEADER
Leadership Advisory
Support for leaders navigating inherited teams, operating-model decisions, and changing organizational priorities.
Advisory for Medical Affairs technology and service providers →
WHY TALMEDICA
An outside view, from someone who has run the inside
Talmedica was founded by Christine Ong, PharmD, whose experience spans early drug development, regulatory strategy, and Medical Affairs leadership. Having built and led Field Medical teams through launches, transitions, and organizational change, she brings an independent perspective informed by the decisions and constraints leaders face inside pharmaceutical organizations.
20+ years across pharma and biotech
Experience spanning scientific development, regulatory, and Medical Affairs leadership.
Built and led Field Medical organizations
Firsthand experience with launch preparation, operating models, capability development, and organizational change.
Development through commercialization
Perspective on how upstream decisions shape what Medical Affairs eventually inherits.
PHARMA SIGNAL
What the market is signaling for Medical Affairs
Pharma Signal examines the decisions, assumptions, and market changes shaping Medical Affairs. From Field Medical effectiveness to launch readiness and evolving HCP needs, each issue looks at where industry practice aligns with the market and where it may need to change.
LAUNCH READINESS
A Field Team Is Not a Launch Plan
Why deploying MSLs is only one part of preparing Medical Affairs for launch.
LEADERSHIP
The Leadership Transition We Don't Prepare For
What changes when experienced professionals become accountable for leading an organization.
MEDICAL AFFAIRS STRATEGY
Before You Lock Your 2027 Medical Affairs Plan
Four questions worth asking before finalizing next year's Medical Affairs priorities and resources.
Read by 20,000+ pharmaceutical and Medical Affairs professionals on LinkedIn.
Request an advisory discussion
Tell me a little about what your organization is navigating. I'll respond personally within 48 hours.